Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-10 11:32 am Sale | 13G | REATA PHARMACEUTICALS INC RETA | Invesco Ltd. IVZ | 2,280,409 7.2% | -1,157,169 (-33.66%) | View |
| 2022-02-10 08:32 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | VANGUARD GROUP INC | 2,557,673 8.13% | 237,642 (+10.24%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | REATA PHARMACEUTICALS INC RETA | BlackRock Inc. BLK | 2,114,050 6.7% | 737,966 (+53.63%) | View |
| 2022-02-04 09:22 am Sale | 13G | REATA PHARMACEUTICALS INC RETA | WELLINGTON MANAGEMENT GROUP LLP | 4,252,977 13.51% | -92,747 (-2.13%) | View |
| 2021-09-10 10:22 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | Invesco Ltd. IVZ | 3,437,578 10.9% | 1,658,103 (+93.18%) | View |
| 2021-02-12 6:48 pm Purchase | 13G | REATA PHARMACEUTICALS INC RETA | Invesco Ltd. IVZ | 1,779,475 5.7% | 1,779,475 (New Position) | View |
| 2021-02-10 11:47 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | VANGUARD GROUP INC | 2,320,031 7.47% | 153,145 (+7.07%) | View |
| 2021-02-04 09:57 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | WELLINGTON MANAGEMENT GROUP LLP | 4,345,724 13.99% | 1,324,800 (+43.85%) | View |
| 2020-12-29 5:31 pm Purchase | 13D | REATA PHARMACEUTICALS INC RETA | CPMG Inc | 5,030,056 15.2% | 1,269 (+0.03%) | View |
| 2020-12-09 10:06 am Purchase | 13D | REATA PHARMACEUTICALS INC RETA | ROSE WILLIAM | 3,215,700 9.7% | 8,519 (+0.27%) | View |
| 2020-10-09 09:14 am Sale | 13G | REATA PHARMACEUTICALS INC RETA | BlackRock Inc. BLK | 1,376,084 4.8% | -867,787 (-38.67%) | View |
| 2020-04-09 08:53 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | WELLINGTON MANAGEMENT GROUP LLP | 3,020,924 10.82% | 628,250 (+26.26%) | View |
| 2020-02-12 09:26 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | VANGUARD GROUP INC | 2,166,886 7.87% | 908,652 (+72.22%) | View |
| 2020-02-06 09:09 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | BlackRock Inc. BLK | 2,243,871 8.2% | 285,707 (+14.59%) | View |
| 2020-01-28 09:31 am Purchase | 13G | REATA PHARMACEUTICALS INC RETA | WELLINGTON MANAGEMENT GROUP LLP | 2,392,674 8.69% | 2,392,674 (New Position) | View |
| 2019-11-20 11:55 am Purchase | 13D | REATA PHARMACEUTICALS INC RETA | ROSE WILLIAM | 3,207,181 10.8% | 9,968 (+0.31%) | View |